Regeneron Pharmaceuticals Inc. buy Morgan Stanley
Start price
03.11.23
/
50%
€764.50
Target price
03.11.24
€854.04
Performance (%)
1.87%
End price
04.11.24
€778.80
Summary
This prediction ended on 04.11.24 with a price of €778.80. The BUY prediction by Morgan_Stanley finished with a performance of 1.87%. Morgan_Stanley has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Morgan_Stanley has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -5.777% | -5.777% | -47.652% |
| iShares Core DAX® | -0.693% | 2.143% | 24.303% |
| iShares Nasdaq 100 | -1.173% | 1.632% | 12.915% |
| iShares Nikkei 225® | -1.388% | 2.138% | 7.771% |
| iShares S&P 500 | -1.411% | 0.648% | 7.222% |
Comments by Morgan_Stanley for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Morgan Stanley from $915.00 to $914.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€779.00
01.11.24
01.11.24
€1,092.0
01.11.25
01.11.25
-37.12%
07:30
07:30
Stopped prediction by Morgan_Stanley for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€480.30
10.10.25
10.10.25
€653.56
10.10.26
10.10.26
1.44%
07:30
07:30
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€479.90
10.07.25
10.07.25
€642.11
10.07.26
10.07.26
1.70%
07:30
07:30
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€428.20
02.06.25
02.06.25
€664.02
02.06.26
02.06.26
13.98%
07:30
07:30
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€995.00
11.07.24
11.07.24
€1,087.6
11.07.25
11.07.25
-51.07%
12.07.25
12.07.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€883.50
18.03.24
18.03.24
€1,025.4
18.03.25
18.03.25
-30.96%
19.03.25
19.03.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€785.00
11.10.23
11.10.23
€861.38
11.10.24
11.10.24
17.78%
12.10.24
12.10.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€692.50
04.08.23
04.08.23
€828.28
04.08.24
04.08.24
42.96%
05.08.24
05.08.24